Back to Search Start Over

Impact of <scp>SARS‐CoV‐</scp> 2 infection on risk of prematurity, birthweight and obstetric complications: A multivariate analysis from a nationwide, population‐based retrospective cohort study

Authors :
Emmanuel Simon
Jean‐Bernard Gouyon
Jonathan Cottenet
Sonia Bechraoui‐Quantin
Patrick Rozenberg
Anne‐Sophie Mariet
Catherine Quantin
HAL UVSQ, Équipe
CHU Dijon
Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon)
Centre d'Études Périnatales de l'Océan Indien (CEPOI)
Université de La Réunion (UR)-Centre Hospitalier Universitaire de La Réunion (CHU La Réunion)
Service Biostatistiques et Informatique Médicale (CHU de Dijon) (DIM)
Université de Versailles Saint-Quentin-en-Yvelines - UFR Sciences de la santé Simone Veil (UVSQ Santé)
Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)
Centre hospitalier intercommunal de Poissy/Saint-Germain-en-Laye - CHIPS [Poissy]
Centre d'Investigation Clinique 1432 (Dijon) - Epidemiologie Clinique/Essais Cliniques (CIC-EC)
Université de Bourgogne (UB)-Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Centre de recherche en épidémiologie et santé des populations (CESP)
Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay
Agence Nationale de la Recherche, ANR
The project was funded by the French National Research Agency.
Source :
BJOG: An International Journal of Obstetrics and Gynaecology, BJOG: An International Journal of Obstetrics and Gynaecology, 2022, 129 (7), pp.1084-1094. ⟨10.1111/1471-0528.17135⟩
Publication Year :
2022
Publisher :
Wiley, 2022.

Abstract

To determine the impact of maternal coronavirus disease 2019 (COVID-19) on prematurity, birthweight and obstetric complications.Nationwide, population-based retrospective cohort study.National Programme de M&#233;dicalisation des Syst&#232;mes d&#39;Information database in France.All single births from March to December 2020: 510 387 deliveries, including 2927 (0.6%) with confirmed COVID-19 in the mother and/or the newborn.The group with COVID-19 was compared with the group without COVID-19 using the chi-square test or Fisher&#39;s exact test, and the Student&#39;s t test or Mann-Whitney U test. Logistic regressions were used to study the effect of COVID-19 on the risk of prematurity or macrosomia (birthweight ≥4500 g).Prematurity less than 37, less than 28, 28-31, or 32-36 weeks of gestation; birthweight; obstetric complications.In singleton pregnancies, COVID-19 was associated with obstetric complications such as hypertension (2.8% versus 2.0%, p 0.01), pre-eclampsia (3.6% versus 2.0%, p 0.01), diabetes (18.8% versus 14.4%, p 0.01) and caesarean delivery (26.8% versus 19.7%, p 0.01). Among pregnant women with COVID-19, there was more prematurity between 28 and 31 weeks of gestation (1.3% versus 0.6%, p 0.01) and between 32 and 36 weeks of gestation (7.7% versus 4.3%, p 0.01), and more macrosomia (1.0% versus 0.7%, p = 0.04), but there was no difference in small-for-gestational-age newborns (6.3% versus 8.7%, p = 0.15). Logistic regression analysis for prematurity showed an adjusted odds ratio (aOR) of 1.77 (95% CI 1.55-2.01) for COVID-19. For macrosomia, COVID-19 resulted in non-significant aOR of 1.38 (95% CI 0.95-2.00).COVID-19 is a risk factor for prematurity, even after adjustment for other risk factors.The risk of prematurity is twice as high in women with COVID-19 after adjustment for factors usually associated with prematurity.

Details

ISSN :
14710528 and 14700328
Volume :
129
Database :
OpenAIRE
Journal :
BJOG: An International Journal of Obstetrics & Gynaecology
Accession number :
edsair.doi.dedup.....2c97bf78c6bd1876577ce8e0701fba4d
Full Text :
https://doi.org/10.1111/1471-0528.17135